A detailed history of Center Book Partners LP transactions in Neuronetics, Inc. stock. As of the latest transaction made, Center Book Partners LP holds 106,650 shares of STIM stock, worth $379,674. This represents 0.02% of its overall portfolio holdings.

Number of Shares
106,650
Previous 326,126 67.3%
Holding current value
$379,674
Previous $1.2 Million 69.0%
% of portfolio
0.02%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025

SELL
$3.32 - $4.65 $728,660 - $1.02 Million
-219,476 Reduced 67.3%
106,650 $372,000
Q1 2025

May 09, 2025

BUY
$1.49 - $5.54 $485,927 - $1.81 Million
326,126 New
326,126 $1.2 Million

Others Institutions Holding STIM

About Neuronetics, Inc.


  • Ticker STIM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 27,022,800
  • Market Cap $96.2M
  • Description
  • Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive diso...
More about STIM
Track This Portfolio

Track Center Book Partners LP Portfolio

Follow Center Book Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Center Book Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Center Book Partners LP with notifications on news.